Standard BioTools (LAB) Reports Q2 Loss, Misses Revenue Estimates

Standard BioTools (LAB) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to loss of $0.14 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -33.33%. A quarter ago, it was expected that this company that makes equipment to control fluids would post a loss of $0.09 per share when it actually produced a loss of $0.23, delivering a surprise of -155.56%. Over the ...